guanidine has been researched along with astatine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Affleck, DJ; Bigner, DD; Vaidyanathan, G; Zalutsky, MR | 1 |
| Affleck, DJ; Alston, KL; Babich, J; Hens, M; Hunter, DH; Vaidyanathan, G; Zalutsky, MR; Zhao, XG | 1 |
| Lunin, VG; Pozzi, OR; Rosenkranz, AA; Sobolev, AS; Vaidyanathan, G; Zalutsky, MR | 1 |
3 other study(ies) available for guanidine and astatine
| Article | Year |
|---|---|
N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with alpha-particle emitting 211At.
Topics: Acylation; Animals; Antibodies, Monoclonal; Astatine; Benzoates; ErbB Receptors; Guanidine; Mice; Radiopharmaceuticals; Tissue Distribution | 2003 |
A kit method for the high level synthesis of [211At]MABG.
Topics: 3-Iodobenzylguanidine; Astatine; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Chromatography, Thin Layer; Guanidine; Half-Life; Indicators and Reagents; Isotope Labeling; Quality Control; Radioisotopes; Radiopharmaceuticals; Spectrophotometry, Ultraviolet; Tin | 2007 |
Engineered modular recombinant transporters: application of new platform for targeted radiotherapeutic agents to alpha-particle emitting 211 At.
Topics: Alpha Particles; Antigens, Polyomavirus Transforming; Astatine; Benzoates; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Nucleus; Confidence Intervals; Dihydropteridine Reductase; Diphtheria Toxin; Drug Carriers; Endosomes; Epidermal Growth Factor; ErbB Receptors; Escherichia coli Proteins; Glioblastoma; Guanidine; Guanidines; Hemeproteins; Humans; NADH, NADPH Oxidoreductases; Radioimmunotherapy | 2008 |